Sumitop 100 mg Centurion Laboratories

£54.00

Sumitop 100 mg represents Centurion Laboratories’ pharmaceutical-grade sumatriptan formulation, providing researchers with standardised migraine medication for comprehensive neurological studies and receptor interaction analysis.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Sumitop 100 mg Centurion Laboratories
Sumitop 100 mg Centurion Laboratories
£54.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

About Sumitop

Sumitop 100 mg is a pharmaceutical preparation containing sumatriptan succinate, manufactured by Centurion Laboratories for in-vitro research applications. This compound belongs to the triptan class of selective 5-HT1B/1D receptor agonists, widely investigated in neurological research protocols examining migraine pathophysiology and serotonin receptor mechanisms. Researchers at Stroid UK Shop utilise this standardised formulation to study vascular smooth muscle responses and neural pathway modulation in laboratory settings.

Laboratory Applications

Sumitop enables researchers to investigate serotonin receptor binding profiles and cranial vasculature responses in controlled experimental environments. Scientists examining migraine mechanisms analyse how sumatriptan interacts with 5-HT1B receptors on cranial blood vessels and 5-HT1D receptors on trigeminal nerve terminals. This compound proves valuable for researchers studying neurovascular inflammation, comparing sumatriptan research compounds with other therapeutic approaches including SARM investigations and peptide research. The pharmaceutical-grade formulation ensures consistent dosing protocols across multiple experimental trials, enabling reproducible data collection in neurological receptor studies.

Product Specifications

Sumitop 100 mg Technical Data
Active Ingredient Sumatriptan Succinate
Strength 100 mg per tablet
Manufacturer Centurion Laboratories
Form Oral tablets
CAS Number 103628-46-2 (succinate salt)
Molecular Formula C₁₄H₂₁N₃O₂S·C₄H₆O₄
Storage Room temperature, dry environment

Research Compliance

This product is manufactured exclusively for in-vitro laboratory research purposes. Sumitop 100 mg is not intended for human consumption, clinical application, or therapeutic use. Researchers must maintain appropriate laboratory protocols when handling this compound and ensure compliance with institutional research guidelines. All investigations should be conducted within approved research facilities with proper safety equipment and documentation procedures.

Related